COWEN AND COMPANY LLC 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:00 pm Sale | 2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL | COWEN AND COMPANY LLC | 0 0.000% | -3,732,778 (Position Closed) | Filing |
| 2022-01-21 11:12 am Purchase | 2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | COWEN AND COMPANY LLC | 3,732,778 6.370% | 691,154 (+22.72%) | Filing |
| 2021-11-12 2:11 pm Purchase | 2021-11-09 | 13G | Avadel Pharmaceuticals plc AVDL | COWEN AND COMPANY LLC | 3,041,624 5.180% | 3,041,624 (New Position) | Filing |